GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE-Reference-Cited by-同舟云学术

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Published:2004-02-20 Issue:3 Volume:32 Page:281-290
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Wells Peter G.,Mackenzie Peter I.,Roy Chowdhury Jayanta,Guillemette Chantal,Gregory Philip A.,Ishii Yuji,Hansen Antony J.,Kessler Fay K.,Kim Perry M.,Roy Chowdhury Namita,Ritter Joseph K.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference103 articles.

1. Chromosomal Localization, Structure, and Regulation of theUGT2B17Gene, Encoding a C19 Steroid Metabolizing Enzyme

2. Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor 1

3. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?

4. Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs;Pharmaceutical Research;2024-08

2. Population-scale variability of the human UDP-glycosyltransferase gene family;Journal of Genetics and Genomics;2024-07

3. Cyanoacetohydrazide as a Novel Derivatization Agent for the Determination of UHPLC-HRMS Steroids in Urine;Molecules;2024-05-22

4. Inhibition of Uridine 5′-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies;In Silico Pharmacology;2024-01-08

5. Connecting biotransformation with toxicity;Public Health and Toxicology Issues Drug Research, Volume 2;2024